Login / Signup
Letter: loss of response to anti-TNFα agents in patients with inflammatory bowel disease depends on treatment duration.
Shomron Ben-Horin
Bella Ungar
Published in:
Alimentary pharmacology & therapeutics (2022)
Keyphrases
</>
patients with inflammatory bowel disease
rheumatoid arthritis
combination therapy
replacement therapy